The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 09, 2016

Filed:

Jul. 29, 2009
Applicants:

John Yu, La Jolla, CA (US);

Alice Yu, La Jolla, CA (US);

Ming-wei Kuo, Sanchong, TW;

Jui-chin Chang, Taipei, TW;

Inventors:

John Yu, La Jolla, CA (US);

Alice Yu, La Jolla, CA (US);

Ming-Wei Kuo, Sanchong, TW;

Jui-Chin Chang, Taipei, TW;

Assignee:

Academia Sinica, Taipei, TW;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C12N 15/113 (2010.01); C12Q 1/68 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4747 (2013.01); A61K 48/005 (2013.01); C07K 16/18 (2013.01); C12N 15/113 (2013.01); C12Q 1/6876 (2013.01); G01N 33/6854 (2013.01); C12N 2799/025 (2013.01);
Abstract

Methods and compositions for treating retinal diseases comprising therapeutic amounts of a compound selected from a normal Puf-A gene product, an active polypeptide fragment thereof, an analog thereof or a peptidomimetic thereof. Vectors, including AAV vectors comprising the therapeutic compound are provided. Puf-A compositions suitable for subretinal, intravitreal, topical, subconjunctival, retrobulbar, periocular, suprachoroidal, or intraocular administration are provided. Methods for screening siRNA, RNAi and shRNA, small molecules and monoclonal antibodies that inhibit Puf-A target activity and reduce apoptosis are provided.


Find Patent Forward Citations

Loading…